What does governance look like in homecare?

Similar documents
Guidance notes for patient safety and pharmacovigilance in patient support programmes

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Pharmacovigilance Training

Good Practice Principles:

Section 7: Core clinical headings

1. PURPOSE 2. SCOPE 3. RESPONSIBILITIES

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

NHMC. Homecare Medicines Services: National Homecare Medicines Committee. History

Managing medicines in care homes

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Corporate Induction: Part 2

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

MEDICINES CONTROL COUNCIL

Section 6: Referral record headings

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

MEDICINES CONTROL COUNCIL

14 th May Pharmacy Voice. 4 Bloomsbury Square London WC1A 2RP T E

Medicines Reconciliation: Standard Operating Procedure

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

All Wales Multidisciplinary Medicines Reconciliation Policy

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

3 HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

Central Alerting System (CAS) Policy

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Guidance for registered pharmacies preparing unlicensed medicines

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

Reconciliation of Medicines on Admission to Hospital

Standards for the initial education and training of pharmacy technicians. October 2017

Consultation on initial education and training standards for pharmacy technicians. December 2016

How to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS)

abcdefghijklmnopqrstu

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

Licensed Pharmacy Technicians Scope of Practice

NMC programme of change for education Prescribing and standards for medicines management

Improving compliance with oral methotrexate guidelines. Action for the NHS

JOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.

Practising as a midwife in the UK

Reducing Medication Errors

Job Description. Post Title Directorate Reports to Responsible for Key Relationships

Section Title. Prescribing competency framework Catherine Picton, Lead author

Date of publication:june Date of inspection visit:18 March 2014

The Code Standards of conduct, performance and ethics for chiropractors. Effective from 30 June 2016

nhs voice: we re listening NHS client experience survey results December 2015 January 2016

EMERGENCY CARE DISCHARGE SUMMARY

MEDICINES CONTROL COUNCIL

NMC programme of change for education Prescribing and standards for medicines management

Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02

Unlicensed Medicines Policy Document

Section 3: Handover record headings

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.

Pre-registration. e-portfolio

Policy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Clinical Governance & Risk Management Awareness. Incl. investigation of accidents, complaints and claims. Unit 2

Improving the reporting of medication-related safety incidents

Medication Management Policy and Procedures

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Unlicensed Medicines Policy

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Management of medicines shortages in Ireland

Vaccination Recording

Isotretinoin : Review of the Pregnancy Prevention Programme

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

FOOD AND DRUGS AUTHORITY GUIDELINES FOR QUALIFIED PERSON FOR PHARMACOVIGILANCE

Practice Standards and Guidelines for Nurses and Midwives with Prescriptive Authority (3rd Edition)

Regulation Directorate Key Performance Indicators

User Requirements Specification. Family Health Assessment. For. Version v.10. Prepared by BSO. December FHA URS v 10 MC

Safeguarding public health. The New PV Legislation its Impact on PV & MI

SAFEGUARDING CHILDEN POLICY. Policy Reference: Version: 1 Status: Approved

STANDARD OPERATING PROCEDURE

Standard Operating Procedure

Safety Reporting in Clinical Research Policy Final Version 4.0

Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Central Alert System (CAS) RISK MANAGEMENT POLICY /PROCEDURE: CENTRAL ALERT SYSTEM (CAS)

Evaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE

Chapter 13. Documenting Clinical Activities

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

High level guidance to support a shared view of quality in general practice

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.

Unlicensed Medicines Policy

97% 18% 2% self-employed/ freelancer/contractor. 30% part time. 27% Part time

Prevention and control of healthcare-associated infections

Briefing Session. January 2018 /

Occupation Description: Responsible for providing nursing care to residents.

McKinley T34 Ambulatory syringe pump Used in the provision of adult palliative and end of life care

National Radiation Safety Committee, HSE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients

Expiry Date: January 2009 Template Version: Page 1 of 7

Coastal West Sussex Interface Prescribing Policy

Transcription:

What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd

Definitions Clinical governance is a systematic approach to maintaining and improving the quality of patient care within a health system This definition is intended to embody three key attributes: recognisably high standards of care, transparent responsibility and accountability for those standards, and a constant dynamic of improvement The concept has some parallels with the more widely known corporate governance, in that it addresses those structures, systems and processes that assure the quality, accountability and proper management of an organisation's operation and delivery of service. Integrated governance has emerged to refer jointly to the corporate governance and clinical governance duties of healthcare organisations.

What should be measured in clinical homecare governance? 4 23/11/15 Version 1

CQC governance regulation Care Quality Commission Regulation 17: Good governance Health and Social Care Act 2008 (Regulated Activities) Regulations 2014: Regulation 17 Providers must have effective governance, including assurance and auditing systems or processes. These must assess, monitor and drive improvement in the quality and safety of the services provided, including the quality of the experience for people using the service. The systems and processes must also assess, monitor and mitigate any risks relating the health, safety and welfare of people using services and others. Providers must continually evaluate and seek to improve their governance and auditing practice. In addition, providers must securely maintain accurate, complete and detailed records in respect of each person using the service and records relating the employment of staff and the overall management of the regulated activity. As part of their governance, providers must seek and act on feedback from people using the service, those acting on their behalf, staff and other stakeholders, so that they can continually evaluate the service and drive improvement.

RPS Handbook for Homecare

New RPS Handbook Appendix 2016 Further guidance on managing incidents and complaints The NHS Medicines Homecare Committee subgroup working on the national standard for Key Performance Indicators in 2014 resolved that the complexity and diversity of complaint, incident and non-conformance processes between organisations meant it was not possible at that time to agree national standard governance KPIs. Furthermore differences in terminology between NHS Trusts and Homecare providers were causing confusion and undermining trust in the medicines and clinical homecare sector. A stakeholder consultation on draft guidance on managing incidents and complaints and KPI s is underway and a new appendix to the RPS homecare handbook will be launched early in 2015

Overlapping definitions Regulators and stakeholders Patient safety Adverse events/ reactions Defective Medicines Information Governance Safeguarding Complaints Care Quality Commission General Pharmaceutical Council Nurses and Midwives Council MHRA Health and Safety Executive NHS England, Scotland, Wales and Northern Ireland Health and Social Care Information Centre ISO 9001 Pharma Customers NHS Customers Independent Healthcare Customers

Example of a homecare incident / coding A vulnerable adult, that has difficulty self administering their injectable medicine and has very limited support from a carer, is sent their own medicines and medicine intended for another patient. The patient does not detect that the additional medicines are labelled with the other patients name, and self administers these medicine. As a result the patient experiences symptoms as a direct result of the additional medicines and has to be admitted to hospital Incident codes/investigations to be associated with this incident: Adverse event Patient safety incident Safeguarding incident Information governance incident Formal complaint

ABPI Guidance on Patient Support Programmes a PSP is defined as a service for direct patient or patient carer interaction or engagement designed to help management of medication and/or disease outcomes. Examples of services provided by healthcare professionals to support: medicine administration medicine adherence, awareness and education

ABPI Guidance on Patient Support Programmes Adverse Event Reporting When the PSP involves direct interaction with patients, there is always the possibility that adverse events or product complaints relating to any of the MAH s products may be mentioned. Adverse event report collection is a mandatory requirement when conducting PSPs due to the European wide legislation governing PV for pharmaceutical companies. Careful consideration should be given to the design and collation of data to ensure compliance with relevant pharmacovigilance legislation and reporting requirements. Therefore, it is strongly recommended PSPs are designed in collaboration with pharmacovigilance, clinical and legal colleagues.

Adverse events wide definition No causality requirement and 100% reporting compliance required by Pharma Any untoward (medical) occurrence temporally associated with the use of a medicinal product, but not necessarily causally related. This will include harm resulting from dose reductions and discontinuation of drug therapy Abnormal test findings Clinically significant signs and symptoms Changes in physical examination findings Drug abuse Drug dependency Exposure during pregnancy and breastfeeding Extravasation Hypersensitivity Lack of drug efficacy Version 1 Medication errors Misuse Occupational exposure Off-label use Overdose Progression or worsening of the underlying disease Signs and symptoms resulting from drug withdrawal and drug interactions Unexpected beneficial therapeutic effects aside from the use which it has be given

New design for Incident and reporting system in homecare providers Incidents and complaints received from patients carers. reporters Incidents and complaints received from homecare staff Generic data entry into data fields in the patients record / quality database Send to acknowledgement to patient, reporter, clinical referral centre Quality check and triage Adverse events Patient safety Duty of candour Information governance Individual response to patient and/or reporter Investigate, categorise and prepare report Share information with clinical referring centre External reports Incidents and complaints reported directly by post or web Informal complaint no written response required Ensure immediate patient safety Contact clinical referring centre when appropriate Safe guarding Defective clinical products Complaints Take actions to improve systems and services Send information to regulators and stakeholders Internal GDP / GMP nonconformance not involving a patient Data entry into quality database Quality check and triage GDP / GMP nonconformance Investigate, categorise and prepare report External reports

Example of an existing Incident and reporting system design clinical homecare providers Adverse (drug) event Email notification Adverse (drug) event team Outlook email folders External report to Pharma Complaints Limited database Complaints resolution team Database - limited codes Response to patient Patient safety incidents Email notification Patient Safety Team Database limited codes Responses Report to NRLS Defective medicine / device Email notification Defective medicine/device teams - spreadsheets Report to industry / MHRA Safeguarding Email notification Safeguarding team spreadsheet Report to NHS/ Social Care, CQC Information governance Email notification Information governance team - spreadsheet Report to HSIC, NHS

Demographic data fields 1 Homecare Incident/complaint number 2 Homecare pa)ent number 3 NHS number 4 Hospital number (Use of NHS Number preferred) 5 Pa)ent surname 6 Pa)ent forename 7 Carers name - for child or vulnerable adult 8 Demographic Date of birth data fields 9 Gender 10 Ethnicity 11 Address 12 Loca)on ( home serng, work, school, care home, nursing home, hospital, other) 13 Country (England, Northern Ireland, Scotland, Wales) 14 Therapy/contract type 15 Medical history 16 Diagnosis 17 Referring centre 18 Clinical services team loca)on - if applicable

Incident data fields 19 Date that the complaint or incident occurred 20 Time that the complaint or incident occurred 21 Date reported 22 Time reported 23 Repor)ng route - which homecare department? 24 Reporter type (Pa)ent, carer, non- clinical, doctor, nurse, pharmacist, other) 25 Name of reporter (if not the pa)ent) 26 Address 27 Telephone 28 Email 29 Was the pa)ent actually harmed? Yes or No 30 Was this event preventable? Yes or No 31 Describe what happened (do not include any personal iden)fiable data) 32 What was the harm and to what part of the body (if applicable) 33 Personal iden)fiable informa)on about the incident or complaint 34 Immediate correc)ve and preventa)ve ac)ons taken 35 For medical products - does the reporter agree to be contacted by the manufacturer to obtain more informa)on? Yes or No 36 For complaints - does the pa)ent/reporter require a wri^en response? Yes or No 37 A^ach documents, audio recording, photographs etc to describe the incident 38 Name of homecare staff comple)ng the complaint/incident report 39 Contact details of homecare staff comple)ng the report

Medicine and medical device data fields 40 Approved medicine name or 41 Proprietary medicine name Form (oral solid, oral liquid, injec)on, to be 42 applied to the skin, other) 43 Strength 44 Frequency 45 Route 46 Manufacturer 47 Batch number 48 Expiry date 49 Is the product available for inspec)on? 50 If yes, specify loca)on 51 52 In you opinion how likely is this event due to the use of medicine Details of other medicines being taken at the same )me 53 Name of medical device 54 Model 55 Catalogue number 56 Serial number 57 Manufacturer 58 Supplier 59 Batch number 60 Expiry date 61 Date of manufacture 63 Is the device available for inspec)on? Loca)on

Proposed new KPI s for incidents and complaint reporting Overarching incident / complaint process 1 Number of incidents / complaints requiring written response acknowledged within 3 working days as a % of number of incidents / complaints requiring written response received 2 Number of overdue incidents / complaints requiring written response as a % of number of incidents / complaints requiring written response received 3 Number of appeal requests received for any written response to an incident / complaint as a % of total number of incidents / complaints requiring written response received 4 5 Number of open incidents / complaints requiring written response as a % of number of incidents / complaints requiring written response received Number of days longest open incident / complaint requiring written response has been open and remains open at point of report generation

Proposed new KPI s for incidents and complaint reporting Patient Safety Incidents 6 Number of patient safety incidents(moderate death) as % of number of active patients 7 Number of patient safety incidents (low no harm) as % of number of active patients 8 Number of patient safety Incidents (low death) as % of number of patient safety incidents reported Adverse events and adverse drug reactions 9 10 11 Total number of reported adverse drug reaction incidents as a % of number of active patients Number of adverse drug reaction incidents (Moderate death) as % of number of active patients Number of adverse drug reaction incidents (low no harm) as % of number of active patients 12 Total number of reported adverse event incidents as a % of number of active patients 13 Number of Adverse event incidents (Moderate death) as % of number of active patients

Proposed new KPI s for incidents and complaint reporting Faulty medicine and medical device products 14 Total number of faulty medicine product incident reports 15 Total number of faulty medicine device incident reports Safeguarding incidents 16 Total number of safeguarding incidents 17 Number of safeguarding incidents relating to children 18 Number of safeguarding incidents relating to adults Information governance incidents 19 Number of level 0 information governance incidents as a % of active patients 20 Number of level 1 information governance incidents as a % of active patients 21 Number of level 2 information governance incidents as a % of active patients

Proposed new KPI s for incidents and complaint reporting Complaints 22 Number of informal complaints received as a % of active patients 23 Number of formal complaints received as a % of active patients

An example of a important patient safety concern in homecare Late homecare prescriptions from the NHS accounts for over 50% of patient safety incidents reports in HAH

Homecare prescription management process - repeat prescriptions 5 Weeks before planned delivery date request repeat prescription 2 weeks before planned delivery date planned call date to arrange delivery send reminder On day of planned delivery send reminder Each week after the planned delivery date send reminder

Example incident Date reported: 15/06/2015 Therapy: Biopharmaceutical Clinical Outcome: Moderate harm Details of the incident report: The patient contacted HAH on 11/06 to say that they had missed treatment. Chronology of events: 31/03 - Prescription requested 30/04 Prescription requested another 5 times 22/05 - Inbound call from patient - no prescription, advised 2 injections missed 27/05 - Inbound call patient going to contact the hospital. 27/05 - Inbound call Patient advised prescriber had sent the prescription to their pharmacy to have the purchase order number attached and then this will be sent to HAH 03/06 - Prescription requested 08/06 - Prescription received with no purchase order number - queried with hospital 08/06 - Outbound call to hospital to confirm purchase order number - no answer 09/06 -Outbound call to patient; HAH Pharmacist gave advice on missed dose, at this point the patient had missed 11 injections 10/06 - Inbound call - Prescription query no purchase order number 10/06 - Prescription query resolved - delivery can be arranged 10/06 - Delivery confirmed 12/06 25

Action to address late homecare prescriptions Raise awareness work with the NHS to minimise the risk Share prescription requests and late prescription reports with with hospital chief pharmacists/homecare staff and prescribers Introduce a more formal communication process to place a patient account on hold A new escalation process for late prescriptions. With the end stage that HAH places the patients account awaiting prescription and formally communicating this to the NHS referral centre and patient Clarify use of faxed prescriptions only for emergencies according to GPHc guidance Clarify minimum standards for collection, delivery and acknowledgement of physical prescriptions Investigate the use of electronic prescribing/trading systems for homecare

Ques>ons? #pharmanforum